Drug
LP-005 Injection
LP-005 Injection is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Not yet recruiting3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
not_yet_recruiting375%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis
NCT07603713
not_yet_recruitingphase_2
Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease
NCT07363265
active_not_recruitingphase_2
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
NCT07212426
not_yet_recruitingphase_2
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT07266155
Clinical Trials (4)
Showing 4 of 4 trials
NCT07603713Phase 2
Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis
NCT07363265Phase 2
Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease
NCT07212426Phase 2
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
NCT07266155Phase 2
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4